An estimated 2.56 percent of U.S. adults ages 40 years and older have glaucoma, according to a study published online Oct. 17 ...

Glaucoma is the leading cause of irreversible blindness in the world, and more than half of glaucoma cases in the U.S. are ...

A large number of studies have focused on mental health declines associated with glaucoma. For example, about one-third of ...

Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to ...

Glaucoma is a serious eye condition that affects dogs. It occurs when there is an imbalance in the production and drainage of ...

Glaucoma Therapeutics MarketThe global glaucoma therapeutics market is projected to be valued at approximately USD 6.9 ...

This meta-analysis found that an estimated 2.56% of people 40 years or older have glaucoma, slightly more than estimated by ...

Researchers found that higher levels of chronic stress, measured by allostatic load (AL), increase the risk of having ...

SpyGlass Pharma released 18-month follow-up data highlighting the potential of its (IOL)-based drug delivery platform.

In another Gazzette notification, the drug pricing regulator fixed the retail price of 20 new drugs under the provisions of ...

Glaucoma in dogs is a painful condition caused by high pressure within the eye. Two types of glaucoma can affect our canine companions: primary and secondary. Glaucoma can lead to blindness if it ...